Health Ministry Assures GP Operations Won't Be Disrupted by New Drug Price Display Law
The health ministry has moved to allay concerns that the implementation of the Price Control and Anti-Profiteering Act 2011, which mandates the display of drug prices, will disrupt the operations of private general practitioners (GPs) in Malaysia. According to the ministry, the move is aimed at promoting transparency and fairness in the pricing of pharmaceutical products, thereby protecting consumers from overpricing. By making drug prices more visible, the ministry hopes to encourage competition among pharmacies and clinics, ultimately leading to more affordable healthcare options for Malaysians. The use of digital platforms and online pharmacy services is also expected to increase, making it easier for people to compare prices and make informed decisions about their healthcare needs. With the help of healthcare technology and medical tourism, Malaysia is poised to become a hub for affordable and quality healthcare in the region. The health ministry's assurance is seen as a positive step towards maintaining the smooth operation of private GPs while promoting consumer protection and affordable healthcare.